-
1
-
-
1542298267
-
Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone
-
Workman P. Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone. Cancer Lett 2004;206:149-57.
-
(2004)
Cancer Lett
, vol.206
, pp. 149-157
-
-
Workman, P.1
-
2
-
-
35348890981
-
Drugging the cancer chaperone HSP90: Combinatorial therapeutic exploitation of oncogene addiction and tumor stress
-
Workman P Burrows F, Neckers L, Rosen N. Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress. Ann N Y Acad Sci 2007;1113:202-16.
-
(2007)
Ann N Y Acad Sci
, vol.1113
, pp. 202-216
-
-
Workman, P.1
Burrows, F.2
Neckers, L.3
Rosen, N.4
-
3
-
-
0036219609
-
Hsp90 inhibitors as novel cancer chemotherapeutic agents
-
Neckers L. Hsp90 inhibitors as novel cancer chemotherapeutic agents. Trends Mol Med 2002;8(4 Suppl):S55-61.
-
(2002)
Trends Mol Med
, vol.8
, Issue.4 SUPPL
-
-
Neckers, L.1
-
4
-
-
34250561475
-
A new pufng pattern induced by temperature shock and DNP in drosophila
-
Ritossa F. A new pufng pattern induced by temperature shock and DNP in drosophila. Cell Mol Life Sci 1962;18:571-3.
-
(1962)
Cell Mol Life Sci
, vol.18
, pp. 571-573
-
-
Ritossa, F.1
-
5
-
-
0030154255
-
Discovery of the heat shock response
-
Ritossa F Discovery of the heat shock response. Cell Stress Chaperones 1996;1:97-8.
-
(1996)
Cell Stress Chaperones
, vol.1
, pp. 97-98
-
-
Ritossa, F.1
-
7
-
-
0026271025
-
The role of heat-shock proteins as molecular chaperones
-
Welch WJ. The role of heat-shock proteins as molecular chaperones. CurrOpin Cell Biol 1991;3:1033-8.
-
(1991)
CurrOpin Cell Biol
, vol.3
, pp. 1033-1038
-
-
Welch, W.J.1
-
8
-
-
0020491477
-
Purification of the major mammalian heat shock proteins
-
Welch WJ, Feramisco JR. Purification of the major mammalian heat shock proteins. J Biol Chem 1982;257:14949-59.
-
(1982)
J Biol Chem
, vol.257
, pp. 14949-14959
-
-
Welch, W.J.1
Feramisco, J.R.2
-
9
-
-
0029564954
-
Heat shock transcription factors: Structure and regulation
-
Wu C. Heat shock transcription factors: structure and regulation. Annu Rev Cell Dev Biol 1995;11:441-69.
-
(1995)
Annu Rev Cell Dev Biol
, vol.11
, pp. 441-469
-
-
Wu, C.1
-
11
-
-
34548658230
-
Heat shock factor 1 is a powerful multifaceted modifer of carcinogenesis
-
Dai C, Whitesell L, Rogers AB, Lindquist S. Heat shock factor 1 is a powerful multifaceted modifer of carcinogenesis. Cell 2007;130:1005-18.
-
(2007)
Cell
, vol.130
, pp. 1005-1018
-
-
Dai, C.1
Whitesell, L.2
Rogers, A.B.3
Lindquist, S.4
-
12
-
-
34547616810
-
Selective suppression of lymphomas by functional loss of Hsf1 in a p53-defcient mouse model for spontaneous tumors
-
Min JN, Huang L, Zimonjic DB, Moskophidis D, Mvechi NF. Selective suppression of lymphomas by functional loss of Hsf1 in a p53-defcient mouse model for spontaneous tumors. Oncogene 2007;26:5086-97.
-
(2007)
Oncogene
, vol.26
, pp. 5086-5097
-
-
Min, J.N.1
Huang, L.2
Zimonjic, D.B.3
Moskophidis, D.4
Mvechi, N.F.5
-
13
-
-
77956929098
-
Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis
-
Meng L, Gabai VL, Sherman MY. Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis. Oncogene 2010;29:5204-13.
-
(2010)
Oncogene
, vol.29
, pp. 5204-5213
-
-
Meng, L.1
Gabai, V.L.2
Sherman, M.Y.3
-
14
-
-
0037040541
-
Molecular chaperones in the cytosol: From nascent chain to folded protein
-
Hartl FU, Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 2002;295:1852-8.
-
(2002)
Science
, vol.295
, pp. 1852-1858
-
-
Hartl, F.U.1
Hayer-Hartl, M.2
-
15
-
-
0027423102
-
Biological and clinical implications of heat shock protein 27,000 (Hsp27): A review
-
Ciocca DR, Oesterreich S, Chamness GC, McGuire WL, Fuqua SA. Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. J Natl Cancer Inst 1993;85:1558-70.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 1558-1570
-
-
Ciocca, D.R.1
Oesterreich, S.2
Chamness, G.C.3
McGuire, W.L.4
Fuqua, S.A.5
-
16
-
-
1642268986
-
Hsp90 isoforms: Functions, expression and clinical importance
-
Sreedhar AS, Kalmár E, Csermely P Shen YF. Hsp90 isoforms: functions, expression and clinical importance. FEBS Lett 2004;562:11 -5.
-
(2004)
FEBS Lett
, vol.562
, pp. 11-15
-
-
Sreedhar, A.S.1
Kalmár, E.2
Csermely, P.3
Shen, Y.F.4
-
17
-
-
77953446392
-
Dual role of heat shock proteins as regulators of apoptosis and innate immunity
-
Joly AL, Wettstein G, Mgnot G, Ghiringhelli F, Garrido C. Dual role of heat shock proteins as regulators of apoptosis and innate immunity. J Innate Immun 2010;2:238-47.
-
(2010)
J Innate Immun
, vol.2
, pp. 238-247
-
-
Joly, A.L.1
Wettstein, G.2
Mgnot, G.3
Ghiringhelli, F.4
Garrido, C.5
-
18
-
-
79960337453
-
Heat shock proteins in oncology: Diagnostic biomarkers or therapeutic targets
-
Khalil AA, Kabapy NF, Deraz SF, Smith C. Heat shock proteins in oncology: diagnostic biomarkers or therapeutic targets? Biochim Biophys Acta 2011;1816:89-104.
-
(2011)
Biochim Biophys Acta
, vol.1816
, pp. 89-104
-
-
Khalil, A.A.1
Kabapy, N.F.2
Deraz, S.F.3
Smith, C.4
-
20
-
-
36749002683
-
Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins
-
Didelot C, Lanneau D, Brunet M, Joly AL, De Tonel A, Chiosis G, et al. Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins. Curr Med Chem 2007; 14:2839-47.
-
(2007)
Curr Med Chem
, vol.14
, pp. 2839-2847
-
-
Didelot, C.1
Lanneau, D.2
Brunet, M.3
Joly, A.L.4
de Tonel, A.5
Chiosis, G.6
-
21
-
-
0027391629
-
Small heat shock proteins are molecular chaperones
-
Jakob U, Gaestel M, Engel K, Buchner J. Small heat shock proteins are molecular chaperones. J Biol Chem 1993;268:1517-20.
-
(1993)
J Biol Chem
, vol.268
, pp. 1517-1520
-
-
Jakob, U.1
Gaestel, M.2
Engel, K.3
Buchner, J.4
-
22
-
-
21744445069
-
Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications
-
Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005;10:86-103.
-
(2005)
Cell Stress Chaperones
, vol.10
, pp. 86-103
-
-
Ciocca, D.R.1
Calderwood, S.K.2
-
23
-
-
0026544498
-
Clinical and biological signifcance of HSP89 alpha in human breast cancer
-
Jameel A, Skilton RA, Campbell TA, Chander SK, Coombes RC, Luq-mani YA. Clinical and biological signifcance of HSP89 alpha in human breast cancer. Int JCancer 1992;50:409-15.
-
(1992)
Int JCancer
, vol.50
, pp. 409-415
-
-
Jameel, A.1
Skilton, R.A.2
Campbell, T.A.3
Chander, S.K.4
Coombes, R.C.5
Luq-Mani, Y.A.6
-
24
-
-
77950866609
-
Te role of Hsp27 and actin in the regulation of movement in human cancer cells responding to heat shock
-
Doshi BM, Hightower LE, Lee J. Te role of Hsp27 and actin in the regulation of movement in human cancer cells responding to heat shock. Cell Stress Chaperones 2009;14:445-57.
-
(2009)
Cell Stress Chaperones
, vol.14
, pp. 445-457
-
-
Doshi, B.M.1
Hightower, L.E.2
Lee, J.3
-
25
-
-
0036366524
-
Small stress proteins: Novel negative modulators of apoptosis induced independently of reactive oxygen species
-
Arrigo AP, Paul C, Ducasse C, Manero F, Kretz-Remy C, Virot S, et al. Small stress proteins: novel negative modulators of apoptosis induced independently of reactive oxygen species. Prog Mol Subcell Biol 2002; 28:185-204.
-
(2002)
Prog Mol Subcell Biol
, vol.28
, pp. 185-204
-
-
Arrigo, A.P.1
Paul, C.2
Ducasse, C.3
Manero, F.4
Kretz-Remy, C.5
Virot, S.6
-
26
-
-
33751203833
-
Heat shock proteins 27 and 70: Anti-apoptotic proteins with tumorigenic properties
-
Garrido C, Brunet M, Didelot C, Zermati Y Schmitt E, Kroemer G. Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle 2006;5:2592-601.
-
(2006)
Cell Cycle
, vol.5
, pp. 2592-2601
-
-
Garrido, C.1
Brunet, M.2
Didelot, C.3
Zermati, Y.4
Schmitt, E.5
Kroemer, G.6
-
27
-
-
0031911082
-
Analysis of diferential protein expression in normal and neoplastic human breast epithelial cell lines
-
Williams K, Chubb C, Huberman E, Giometti CS. Analysis of diferential protein expression in normal and neoplastic human breast epithelial cell lines. Electrophoresis 1998;19:333-43.
-
(1998)
Electrophoresis
, vol.19
, pp. 333-343
-
-
Williams, K.1
Chubb, C.2
Huberman, E.3
Giometti, C.S.4
-
28
-
-
20544460025
-
Expres-sional patterns of chaperones in ten human tumor cell lines
-
Myung JK, Afehi-Sadat L, Felizardo-Cabatic M, Slavc I, Lubec G. Expres-sional patterns of chaperones in ten human tumor cell lines. Proteome Sci 2004;2:8.
-
(2004)
Proteome Sci
, vol.2
, pp. 8
-
-
Myung, J.K.1
Afehi-Sadat, L.2
Felizardo-Cabatic, M.3
Slavc, I.4
Lubec, G.5
-
29
-
-
70349287559
-
Heat shock protein 27 is involved in SUMO-2/3 modif-cation of heat shock factor 1 and thereby modulates the transcription factor activity
-
Brunet Simioni M, De Tonel A, Hammann A, Joly AL, Bossis G, Four-maux E, et al. Heat shock protein 27 is involved in SUMO-2/3 modif-cation of heat shock factor 1 and thereby modulates the transcription factor activity. Oncogene 2009;28:3332-44.
-
(2009)
Oncogene
, vol.28
, pp. 3332-3344
-
-
Brunet Simioni, M.1
de Tonel, A.2
Hammann, A.3
Joly, A.L.4
Bossis, G.5
Four-Maux, E.6
-
30
-
-
38449118227
-
Proteomics fnding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine
-
Mori-Iwamoto S, Kuramitsu Y Ryozawa S, Mkuria K, Fujimoto M, Maehara S, et al. Proteomics fnding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine. Int J Oncol 2007; 31:1345-50.
-
(2007)
Int J Oncol
, vol.31
, pp. 1345-1350
-
-
Mori-Iwamoto, S.1
Kuramitsu, Y.2
Ryozawa, S.3
Mkuria, K.4
Fujimoto, M.5
Maehara, S.6
-
31
-
-
34047132772
-
Heat shock protein 27 is associated with irinotecan resistance in human colorectal cancer cells
-
Choi DH, Ha JS, Lee WH, Song JK, Kim GY Park JH, et al. Heat shock protein 27 is associated with irinotecan resistance in human colorectal cancer cells. FEBS Lett 2007;581:1649-56.
-
(2007)
FEBS Lett
, vol.581
, pp. 1649-1656
-
-
Choi, D.H.1
Ha, J.S.2
Lee, W.H.3
Song, J.K.4
Kim, G.Y.5
Park, J.H.6
-
32
-
-
0032747966
-
Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells
-
Hansen RK, Parra I, Lemieux P Oesterreich S, Hilsenbeck SG, Fuqua SA. Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells. Breast Cancer Res Treat 1999;56:187-96.
-
(1999)
Breast Cancer Res Treat
, vol.56
, pp. 187-196
-
-
Hansen, R.K.1
Parra, I.2
Lemieux, P.3
Oesterreich, S.4
Hilsenbeck, S.G.5
Fuqua, S.A.6
-
33
-
-
54049100335
-
Upregu-lated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability
-
Kang SH, Kang KW, Kim KH, Kwon B, Kim SK, Lee HY et al. Upregu-lated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability. BMC Cancer 2008;8:286.
-
(2008)
BMC Cancer
, vol.8
, pp. 286
-
-
Kang, S.H.1
Kang, K.W.2
Kim, K.H.3
Kwon, B.4
Kim, S.K.5
Lee, H.Y.6
-
34
-
-
0031793127
-
Heat shock protein 70 kDa: Molecular biology biochemistry, and physiology
-
Kiang JG, Tsokos GC. Heat shock protein 70 kDa: molecular biology biochemistry, and physiology. Pharmacol Ter 1998;80:183-201.
-
(1998)
Pharmacol Ter
, vol.80
, pp. 183-201
-
-
Kiang, J.G.1
Tsokos, G.C.2
-
35
-
-
0032768772
-
Heat shock proteins as cellular lifeguards
-
Jäättelä M. Heat shock proteins as cellular lifeguards. Ann Med 1999; 31:261-71.
-
(1999)
Ann Med
, vol.31
, pp. 261-271
-
-
Jäättelä, M.1
-
36
-
-
28744450158
-
Over expression of endoplasmic reticulum molecular chaperone GRP94 and GRP78 in human lung cancer tissues and its significance
-
Wang Q, He Z, Zhang J, Wang Y Wang T, Tong S, et al. Over expression of endoplasmic reticulum molecular chaperone GRP94 and GRP78 in human lung cancer tissues and its significance. Cancer Detect Prev 2005; 29:544-51.
-
(2005)
Cancer Detect Prev
, vol.29
, pp. 544-551
-
-
Wang, Q.1
He, Z.2
Zhang, J.3
Wang, Y.4
Wang, T.5
Tong, S.6
-
37
-
-
0034820026
-
Functional dissection of trigger factor and DnaK interactions with nascent polypeptides and thermally denatured proteins
-
Schaftzel E, Rüdiger S, Bukau B, Deuerling E Functional dissection of trigger factor and DnaK interactions with nascent polypeptides and thermally denatured proteins. Biol Chem 2001;382:1235-43.
-
(2001)
Biol Chem
, vol.382
, pp. 1235-1243
-
-
Schaftzel, E.1
Rüdiger, S.2
Bukau, B.3
Deuerling, E.4
-
38
-
-
0034924812
-
Folding of newly translated proteins in vivo: The role of molecular chaperones
-
Frydman J. Folding of newly translated proteins in vivo: the role of molecular chaperones. Annu Rev Biochem 2001;70:603-47.
-
(2001)
Annu Rev Biochem
, vol.70
, pp. 603-647
-
-
Frydman, J.1
-
39
-
-
0037315208
-
Regulation of signaling protein function and traffcking by the hsp90/hsp70-based chaperone machinery
-
Pratt WB, Tof DO. Regulation of signaling protein function and traffcking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 2003;228:111-33.
-
(2003)
Exp Biol Med (Maywood)
, vol.228
, pp. 111-133
-
-
Pratt, W.B.1
Tof, D.O.2
-
40
-
-
0642377466
-
More than folding: Localized functions of cytosolic chaperones
-
Young JC, Barral JM, Ulrich Hartl F. More than folding: localized functions of cytosolic chaperones. Trends Biochem Sci 2003;28:541-7.
-
(2003)
Trends Biochem Sci
, vol.28
, pp. 541-547
-
-
Young, J.C.1
Barral, J.M.2
Ulrich Hartl, F.3
-
41
-
-
0024975155
-
A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins
-
Chiang HL, Terlecky SR, Plant CP, Dice JF. A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins. Science 1989;246:382-5.
-
(1989)
Science
, vol.246
, pp. 382-385
-
-
Chiang, H.L.1
Terlecky, S.R.2
Plant, C.P.3
Dice, J.F.4
-
42
-
-
0031004769
-
Ubiquitin-dependent degradation of certain protein substrates in vitro requires the molecular chaperone Hsc70
-
Bercovich B, Stancovski I, Mayer A, Blumenfeld N, Laszlo A, Schwartz AL, et al. Ubiquitin-dependent degradation of certain protein substrates in vitro requires the molecular chaperone Hsc70. J Biol Chem 1997;272: 9002-10.
-
(1997)
J Biol Chem
, vol.272
, pp. 9002-9010
-
-
Bercovich, B.1
Stancovski, I.2
Mayer, A.3
Blumenfeld, N.4
Laszlo, A.5
Schwartz, A.L.6
-
43
-
-
2342651518
-
Molecular chaperones and the stress of oncogenesis
-
Mosser DD, Morimoto RI. Molecular chaperones and the stress of oncogenesis. Oncogene 2004;23:2907-18.
-
(2004)
Oncogene
, vol.23
, pp. 2907-2918
-
-
Mosser, D.D.1
Morimoto, R.I.2
-
44
-
-
33947267567
-
High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways
-
Yaglom JA, Gabai VL, Sherman MY High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways. Cancer Res 2007;67:2373-81.
-
(2007)
Cancer Res
, vol.67
, pp. 2373-2381
-
-
Yaglom, J.A.1
Gabai, V.L.2
Sherman, M.Y.3
-
45
-
-
0032582562
-
Role of Hsp70 in regulation of stress-kinase JNK implications in apoptosis and aging
-
Gabai VL, Meriin AB, Yaglom JA, Volloch VZ, Sherman MY. Role of Hsp70 in regulation of stress-kinase JNK implications in apoptosis and aging. FEBS Lett 1998;438:1-4.
-
(1998)
FEBS Lett
, vol.438
, pp. 1-4
-
-
Gabai, V.L.1
Meriin, A.B.2
Yaglom, J.A.3
Volloch, V.Z.4
Sherman, M.Y.5
-
46
-
-
18844378888
-
Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents
-
Gabai VL, Budagova KR, Sherman MY Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents. Oncogene 2005;24:3328-38.
-
(2005)
Oncogene
, vol.24
, pp. 3328-3338
-
-
Gabai, V.L.1
Budagova, K.R.2
Sherman, M.Y.3
-
47
-
-
77953734857
-
Heat shock protein 70 (hsp70) as an emerging drug target
-
Evans CG, Chang L, Gestwicki JE. Heat shock protein 70 (hsp70) as an emerging drug target. J Med Chem 2010;53:4585-602.
-
(2010)
J Med Chem
, vol.53
, pp. 4585-4602
-
-
Evans, C.G.1
Chang, L.2
Gestwicki, J.E.3
-
48
-
-
70449589907
-
Proteomic profiling of heat shock proteins: An emerging molecular approach with direct pathophysiological and clinical implications
-
Bottoni P Giardina B, Scatena R. Proteomic profiling of heat shock proteins: an emerging molecular approach with direct pathophysiological and clinical implications. Proteomics Clin Appl 2009;3:636-53.
-
(2009)
Proteomics Clin Appl
, vol.3
, pp. 636-653
-
-
Bottoni, P.1
Giardina, B.2
Scatena, R.3
-
49
-
-
50349096803
-
Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis
-
Powers MV Clarke PA, Workman P. Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis. Cancer Cell 2008;14:250-62.
-
(2008)
Cancer Cell
, vol.14
, pp. 250-262
-
-
Powers, M.V.1
Clarke, P.A.2
Workman, P.3
-
50
-
-
0141596939
-
Structure and functional relationships of Hsp90
-
Prodromou C, Pearl LH. Structure and functional relationships of Hsp90. Curr Cancer Drug Targets 2003;3:301-23.
-
(2003)
Curr Cancer Drug Targets
, vol.3
, pp. 301-323
-
-
Prodromou, C.1
Pearl, L.H.2
-
51
-
-
0031444238
-
Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone
-
Prodromou C, Roe SM, O'Brien R, Ladbury JE, Piper PW, Pearl LH. Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell 1997;90:65-75.
-
(1997)
Cell
, vol.90
, pp. 65-75
-
-
Prodromou, C.1
Roe, S.M.2
O'Brien, R.3
Ladbury, J.E.4
Piper, P.W.5
Pearl, L.H.6
-
52
-
-
0034711270
-
Te heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized ATP-binding domain in the carboxyl terminus of the chaperone
-
Marcu MG, Chadli A, Bouhouche I, Catelli M, Neckers LM. Te heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized ATP-binding domain in the carboxyl terminus of the chaperone. J Biol Chem 2000;275:37181-6.
-
(2000)
J Biol Chem
, vol.275
, pp. 37181-37186
-
-
Marcu, M.G.1
Chadli, A.2
Bouhouche, I.3
Catelli, M.4
Neckers, L.M.5
-
53
-
-
0036510547
-
A nucleotide-dependent molecular switch controls ATP binding at the C-terminal domain of Hsp90. N-terminal nucleotide binding unmasks a C-terminal binding pocket
-
Söti C, Rácz A, Csermely P. A nucleotide-dependent molecular switch controls ATP binding at the C-terminal domain of Hsp90. N-terminal nucleotide binding unmasks a C-terminal binding pocket. J Biol Chem 2002;277:7066-75.
-
(2002)
J Biol Chem
, vol.277
, pp. 7066-7075
-
-
Söti, C.1
Rácz, A.2
Csermely, P.3
-
54
-
-
18544386399
-
Binding of ATP to heat shock protein 90: Evidence for an ATP-binding site in the C-terminal domain
-
Garnier C, Laftte D, Tsvetkov PO, Barbier P, Leclerc-Devin J, Mllot JM, et al. Binding of ATP to heat shock protein 90: evidence for an ATP-binding site in the C-terminal domain. J Biol Chem 2002;277:12208-14.
-
(2002)
J Biol Chem
, vol.277
, pp. 12208-12214
-
-
Garnier, C.1
Laftte, D.2
Tsvetkov, P.O.3
Barbier, P.4
Leclerc-Devin, J.5
Mllot, J.M.6
-
56
-
-
34447507818
-
Inhibitors of the heat shock response: Biology and pharmacology
-
Powers MV, Workman P. Inhibitors of the heat shock response: biology and pharmacology. FEBS Lett 2007;581:3758-69.
-
(2007)
FEBS Lett
, vol.581
, pp. 3758-3769
-
-
Powers, M.V.1
Workman, P.2
-
57
-
-
0043288724
-
Heat shock protein 90 as a molecular target for cancer therapeutics
-
Isaacs JS, Xu W, Neckers L. Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 2003;3:213-7.
-
(2003)
Cancer Cell
, vol.3
, pp. 213-217
-
-
Isaacs, J.S.1
Xu, W.2
Neckers, L.3
-
58
-
-
0035146685
-
Te co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins
-
Connell P, Ballinger CA, Jiang J, Wu Y, Tompson LJ, Höhfeld J, et al. Te co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol 2001;3:93-6.
-
(2001)
Nat Cell Biol
, vol.3
, pp. 93-96
-
-
Connell, P.1
Ballinger, C.A.2
Jiang, J.3
Wu, Y.4
Tompson, L.J.5
Höhfeld, J.6
-
59
-
-
0027503365
-
Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: Prognostic implications
-
Ciocca DR, Clark GM, Tandon AK, Fuqua SA, Welch WJ, McGuire WL. Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst 1993;85:570-4.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 570-574
-
-
Ciocca, D.R.1
Clark, G.M.2
Tandon, A.K.3
Fuqua, S.A.4
Welch, W.J.5
McGuire, W.L.6
-
60
-
-
0034664030
-
Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9by heat shock protein 90
-
Pandey P, Saleh A, Nakazawa A, Kumar S, Srinivasula SM, Kumar V, et al. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9by heat shock protein 90. EMBO J 2000;19:4310-22.
-
(2000)
EMBO J
, vol.19
, pp. 4310-4322
-
-
Pandey, P.1
Saleh, A.2
Nakazawa, A.3
Kumar, S.4
Srinivasula, S.M.5
Kumar, V.6
-
61
-
-
1142273472
-
Altered states: Selectively drugging the Hsp90 cancer chap-erone
-
Workman P. Altered states: selectively drugging the Hsp90 cancer chap-erone. Trends MolMed 2004;10:47-51.
-
(2004)
Trends MolMed
, vol.10
, pp. 47-51
-
-
Workman, P.1
-
62
-
-
21144432950
-
The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygel-danamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line
-
Price JT, Quinn JM, Sims NA, Vieusseux J, Waldeck K, Docherty SE, et al. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygel-danamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line. Cancer Res 2005;65:4929-38.
-
(2005)
Cancer Res
, vol.65
, pp. 4929-4938
-
-
Price, J.T.1
Quinn, J.M.2
Sims, N.A.3
Vieusseux, J.4
Waldeck, K.5
Docherty, S.E.6
-
63
-
-
0033502429
-
Geldanamycin as a potential anticancer agent: Its molecular target and biochemical activity
-
Neckers L, Schulte TW, Mimnaugh E. Geldanamycin as a potential anticancer agent: its molecular target and biochemical activity. Invest New Drugs 1999;17:361-73.
-
(1999)
Invest New Drugs
, vol.17
, pp. 361-373
-
-
Neckers, L.1
Schulte, T.W.2
Mimnaugh, E.3
-
64
-
-
0031875042
-
The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin
-
Schulte TW, Neckers LM. The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin. Cancer Chemother Pharmacol 1998; 42:273-9.
-
(1998)
Cancer Chemother Pharmacol
, vol.42
, pp. 273-279
-
-
Schulte, T.W.1
Neckers, L.M.2
-
66
-
-
23044441106
-
Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies
-
Banerji U, O'Donnell A, Scurr M, Pacey S, Stapleton S, Asad Y, et al. Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies. J Clin Oncol 2005;23:4152-61.
-
(2005)
J Clin Oncol
, vol.23
, pp. 4152-4161
-
-
Banerji, U.1
O'Donnell, A.2
Scurr, M.3
Pacey, S.4
Stapleton, S.5
Asad, Y.6
-
67
-
-
33746365169
-
Discovery and development of purine-scafold Hsp90 inhibitors
-
Chiosis G. Discovery and development of purine-scafold Hsp90 inhibitors. Curr Top Med Chem 2006;6:1183-91.
-
(2006)
Curr Top Med Chem
, vol.6
, pp. 1183-1191
-
-
Chiosis, G.1
-
68
-
-
30444447639
-
Identification of potent water soluble purine-scafold inhibitors of the heat shock protein 90
-
He H, Zatorska D, Kim J, Aguirre J, Llauger L, She Y, et al. Identification of potent water soluble purine-scafold inhibitors of the heat shock protein 90. J Med Chem 2006;49:381-90.
-
(2006)
J Med Chem
, vol.49
, pp. 381-390
-
-
He, H.1
Zatorska, D.2
Kim, J.3
Aguirre, J.4
Llauger, L.5
She, Y.6
-
69
-
-
40749103835
-
SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers
-
Chandarlapaty S, Sawai A, Ye Q, Scott A, Silinski M, Huang K, et al. SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers. Clin Cancer Res 2008;14:240-8.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 240-248
-
-
Chandarlapaty, S.1
Sawai, A.2
Ye, Q.3
Scott, A.4
Silinski, M.5
Huang, K.6
-
70
-
-
48949119477
-
NVP-AUY922: A small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models
-
Jensen MR, Schoepfer J, Radimerski T, Massey A, Guy CT, Brueggen J et al. NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models. Breast Cancer Res 2008;10:R33.
-
(2008)
Breast Cancer Res
, vol.10
-
-
Jensen, M.R.1
Schoepfer, J.2
Radimerski, T.3
Massey, A.4
Guy, C.T.5
Brueggen, J.6
-
71
-
-
79952752856
-
STA-9090, a small-molecule Hsp90 inhibitor for the potential treatment of cancer
-
Wang Y Trepel JB, Neckers LM, Giaccone G. STA-9090, a small-molecule Hsp90 inhibitor for the potential treatment of cancer. Curr Opin Investig Drugs 2010; 11:1466-76.
-
(2010)
Curr Opin Investig Drugs
, vol.11
, pp. 1466-1476
-
-
Wang, Y.1
Trepel, J.B.2
Neckers, L.M.3
Giaccone, G.4
-
72
-
-
66449094961
-
BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90
-
Lundgren K, Zhang H, Brekken J, Huser N, Powell RE, Timple N, et al. BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90. Mol Cancer Ter 2009;8:921-9.
-
(2009)
Mol Cancer Ter
, vol.8
, pp. 921-929
-
-
Lundgren, K.1
Zhang, H.2
Brekken, J.3
Huser, N.4
Powell, R.E.5
Timple, N.6
-
73
-
-
33846861747
-
Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors
-
Powers MV, Workman P. Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors. Endocr Relat Cancer 2006;13 Suppl 1:S125-35.
-
(2006)
Endocr Relat Cancer
, vol.13
, Issue.SUPPL. 1
-
-
Powers, M.V.1
Workman, P.2
-
74
-
-
0037075232
-
Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2
-
Basso AD, Solit DB, Munster PN, Rosen N. Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2. Oncogene 2002;21:1159-66.
-
(2002)
Oncogene
, vol.21
, pp. 1159-1166
-
-
Basso, A.D.1
Solit, D.B.2
Munster, P.N.3
Rosen, N.4
-
75
-
-
0034890377
-
Modulation of Hsp90 function by ansamycins sensitizes breast cancer cells to chemotherapy-induced apoptosis in an RB- and schedule-dependent manner
-
Münster PN, Basso A, Solit D, Norton L, Rosen N. Modulation of Hsp90 function by ansamycins sensitizes breast cancer cells to chemotherapy-induced apoptosis in an RB- and schedule-dependent manner. Clin Cancer Res 2001;7:2228-36.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 2228-2236
-
-
Münster, P.N.1
Basso, A.2
Solit, D.3
Norton, L.4
Rosen, N.5
-
76
-
-
38849091289
-
Activation of f-bronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cells
-
Xing H, Weng D, Chen G, Tao W, Zhu T, Yang X, et al. Activation of f-bronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cells. Cancer Lett 2008;261:108-19.
-
(2008)
Cancer Lett
, vol.261
, pp. 108-119
-
-
Xing, H.1
Weng, D.2
Chen, G.3
Tao, W.4
Zhu, T.5
Yang, X.6
-
77
-
-
80054733483
-
The role of heat shock proteins 70/90 as potential molecular therapeutic targets in breast cancer
-
Kang HJ, Hong MK, Jung SK, Kim LS. The role of heat shock proteins 70/90 as potential molecular therapeutic targets in breast cancer. J Breast Cancer 2007;10:231-40.
-
(2007)
J Breast Cancer
, vol.10
, pp. 231-240
-
-
Kang, H.J.1
Hong, M.K.2
Jung, S.K.3
Kim, L.S.4
-
78
-
-
34248195608
-
High HSP90 expression is associated with decreased survival in breast cancer
-
Pick E, Kluger Y, Giltnane JM, Moeder C, Camp RL, Rimm DL, et al. High HSP90 expression is associated with decreased survival in breast cancer. Cancer Res 2007;67:2932-7.
-
(2007)
Cancer Res
, vol.67
, pp. 2932-2937
-
-
Pick, E.1
Kluger, Y.2
Giltnane, J.M.3
Moeder, C.4
Camp, R.L.5
Rimm, D.L.6
-
79
-
-
79960985354
-
HSP90 inhibition is efective in breast cancer: A phase II trial of tanespi-mycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab
-
Modi S, Stopeck A, Linden H, Solit D, Chandarlapaty S, Rosen N, et al. HSP90 inhibition is efective in breast cancer: a phase II trial of tanespi-mycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab. Clin Cancer Res 2011; 17:5132-9.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 5132-5139
-
-
Modi, S.1
Stopeck, A.2
Linden, H.3
Solit, D.4
Chandarlapaty, S.5
Rosen, N.6
-
80
-
-
68849101479
-
Retaspimycin hydrochloride (IPI-504): A novel heat shock protein inhibitor as an anticancer agent
-
Hanson BE, Vesole DH. Retaspimycin hydrochloride (IPI-504): a novel heat shock protein inhibitor as an anticancer agent. Expert Opin Investig Drugs 2009;18:1375-83.
-
(2009)
Expert Opin Investig Drugs
, vol.18
, pp. 1375-1383
-
-
Hanson, B.E.1
Vesole, D.H.2
-
81
-
-
75149123144
-
Inhibitors of HSP90 block p95-HER2 signaling in trastuzumab-resistant tumors and suppress their growth
-
Chandarlapaty S, Scaltriti M, Angelini P, Ye Q, Guzman M, Hudis CA, et al. Inhibitors of HSP90 block p95-HER2 signaling in trastuzumab-resistant tumors and suppress their growth. Oncogene 2010;29:325-34.
-
(2010)
Oncogene
, vol.29
, pp. 325-334
-
-
Chandarlapaty, S.1
Scaltriti, M.2
Angelini, P.3
Ye, Q.4
Guzman, M.5
Hudis, C.A.6
-
82
-
-
72249088988
-
Heat shock protein 90 inhibitors: New mode of therapy to overcome endocrine resistance
-
Wong C, Chen S. Heat shock protein 90 inhibitors: new mode of therapy to overcome endocrine resistance. Cancer Res 2009;69:8670-7.
-
(2009)
Cancer Res
, vol.69
, pp. 8670-8677
-
-
Wong, C.1
Chen, S.2
-
83
-
-
66249138886
-
Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models
-
Caldas-Lopes E, Cerchietti L, Ahn JH, Clement CC, Robles AI, Rodina A, et al. Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models. Proc Natl Acad Sci U S A 2009;106:8368-73.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 8368-8373
-
-
Caldas-Lopes, E.1
Cerchietti, L.2
Ahn, J.H.3
Clement, C.C.4
Robles, A.I.5
Rodina, A.6
|